Literature DB >> 10570931

Monoclonal antibodies against the Androctonus australis hector scorpion neurotoxin I: characterisation and use for venom neutralisation.

O Clot-Faybesse1, M Juin, H Rochat, C Devaux.   

Abstract

A series of monoclonal antibodies (mAbs) specific for the alpha-neurotoxin I (Aah I) from the venom of the dangerous Androctonus australis hector scorpion were obtained using carrier protein-coupled toxin. Competitive RIA, receptor assays and mouse toxicity tests were performed to characterise mAbs in terms of affinity and neutralisation. Cross-reactivity studies and two-site ELISA results allowed some classification of mAbs into three groups. One mAb, 9C2, was particularly interesting since it recognised the parent toxin I with a K(D) of 0.15 nM and was also reactive with toxins of the same immunological group. Its ability to neutralise the toxic effect of the parent toxin and the venom fraction has been investigated. This anti-Aah I mAb 9C2, associated with anti-Aah II mAb 4C1, provides a valuable tool to neutralise the toxicity of the venom.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570931     DOI: 10.1016/s0014-5793(99)01179-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

Review 1.  mRNA: A Novel Avenue to Antibody Therapy?

Authors:  Thomas Schlake; Moritz Thran; Katja Fiedler; Regina Heidenreich; Benjamin Petsch; Mariola Fotin-Mleczek
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

2.  Structural insights into antibody sequestering and neutralizing of Na+ channel α-type modulator from old world scorpion venom.

Authors:  Igor P Fabrichny; Grégoire Mondielli; Sandrine Conrod; Marie-France Martin-Eauclaire; Yves Bourne; Pascale Marchot
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

Review 3.  Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs.

Authors:  Eran Diamant; Amram Torgeman; Eyal Ozeri; Ran Zichel
Journal:  Toxins (Basel)       Date:  2015-05-29       Impact factor: 4.546

Review 4.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

5.  Determination of median effective dose (ED50) of scorpion antivenom against scorpion envenomation using a newly developed formula.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  Animal Model Exp Med       Date:  2018-09-25

Review 6.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

Review 7.  Venomous Arachnid Diagnostic Assays, Lessons from Past Attempts.

Authors:  Camila Dias-Lopes; Ana Luiza Paiva; Clara Guerra-Duarte; Franck Molina; Liza Felicori
Journal:  Toxins (Basel)       Date:  2018-09-10       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.